Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance

Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance

Hypoxia is a common feature of solid tumors that has previously been linked to resistance to radiotherapy and chemotherapy, and more recently to immunotherapy. In particular, hypoxic tumors exclude T cells and inhibit their activity, suggesting that tumor cells acquire a mechanism to evade T cell re...

Bibliografske podrobnosti
Main Authors:	Estephan, H, Tailor, A, Parker, R, Kreamer, M, Papandreou, I, Campo, L, Easton, A, Moon, EJ, Denko, N, Ternette, N, Hammond, E, Giaccia, A
Format:	Journal article
Jezik:	English
Izdano:	EMBO Press 2025

Podobne knjige/članki

Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
od: Purcell, A, et al.
Izdano: (2019)

Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens?
od: Melanie eHarriff, et al.
Izdano: (2012-03-01)

Hypoxia-mediated regulation of DDX5 through decreased chromatin accessibility and post-translational targeting restricts R-loop accumulation
od: Leszczynka, K, et al.
Izdano: (2023)

MHC antigens and cancer: implications for T-cell surveillance.
od: Browning, M, et al.
Izdano: (1992)

Identification of antigens presented by MHC for vaccines against tuberculosis
od: Bettencourt, P, et al.
Izdano: (2020)

Identification of antigens presented by MHC for vaccines against tuberculosis
od: Bettencourt, P, et al.
Izdano: (2020)

Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment
od: Moon, EJ, et al.
Izdano: (2014)

Angiogenesis: escape from hypoxia.
od: Coleman, M, et al.
Izdano: (2009)

NNAlign_MA; MHC peptidome deconvolution for accurate MHC binding motif characterization and improved T-cell epitope predictions
od: Alvarez, B, et al.
Izdano: (2019)

Direct Identification of Vaccine-Induced HIV-1-Specific MHC Class I Associated Epitopes by Mass Spectrometry
od: Ternette, N, et al.
Izdano: (2013)

Hypoxia‐mediated regulation of DDX5 through decreased chromatin accessibility and post‐translational targeting restricts R‐loop accumulation
od: Katarzyna B. Leszczynska, et al.
Izdano: (2023-07-01)

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis
od: Bettencourt, P, et al.
Izdano: (2019)

Hypoxia-Driven Immune Escape in the Tumor Microenvironment
od: Alyssa Vito, et al.
Izdano: (2020-04-01)

NetMHCphosPan - Pan-specific prediction of MHC class I antigen presentation of phosphorylated ligands
od: Carina Thusgaard Refsgaard, et al.
Izdano: (2021-10-01)

Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth
od: Nancy P. Echeverri Ruiz, et al.
Izdano: (2021-11-01)

Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells.
od: Shalini Sethumadhavan, et al.
Izdano: (2017-01-01)

Targeting hypoxia: Revival of old remedies
od: Vilaplana-Lopera, N, et al.
Izdano: (2021)

A NIR fluorescent smart probe for imaging tumor hypoxia
od: Kenneth S. Hettie, et al.
Izdano: (2021-10-01)

Mechanisms of tumour escape from immune surveillance
od: Lisiecka Urszula, et al.
Izdano: (2016-12-01)

Editorial: Hypoxia and angiogenesis in cancer
od: Mohammad Malekan, et al.
Izdano: (2024-08-01)

Inhibition of Autophagy by Berbamine Hydrochloride Mitigates Tumor Immune Escape by Elevating MHC-I in Melanoma Cells
od: Jinhuan Xian, et al.
Izdano: (2024-09-01)

The SysteMHC Atlas project.
od: Shao, W, et al.
Izdano: (2017)

Downregulation of type I IFN response in hypoxia as a possible mechanism of immune escape
od: Miar, A, et al.
Izdano: (2019)

Mechanisms Of Hypoxia-Induced Immune Escape In Cancer And Their Regulation By Nitric Oxide
od: Charles Graham, et al.
Izdano: (2015-08-01)

Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
od: Qinghua Wu, et al.
Izdano: (2022-06-01)

The Avian MHC-Antigen System
od: Diana Wesselinova
Izdano: (2002-10-01)

Of mice and the MHC.
od: Grafen, A
Izdano: (1992)

MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
od: Kayla R Wilson, et al.
Izdano: (2018-01-01)

MECHANISM OF MHC-MEDIATED ANTIGEN RECOGNITION BY T-CELLS
od: Bowness, P, et al.
Izdano: (1993)

ROS and cGMP signaling modulate persistent escape from hypoxia in Caenorhabditis elegans.
od: Lina Zhao, et al.
Izdano: (2022-06-01)

Monoclonal antibodies to rat leukocyte surface antigens, MHC antigens, and immunoglobulins.
od: Puklavec, M, et al.
Izdano: (2001)

Mutational Escape in HIV-1 CTL Epitopes Leads to Increased Binding to Inhibitory Myelomonocytic MHC Class I Receptors
od: Yang, Yue, et al.
Izdano: (2011)

Mutational escape in HIV-1 CTL epitopes leads to increased binding to inhibitory myelomonocytic MHC class I receptors.
od: Yue Yang, et al.
Izdano: (2010-12-01)

Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
od: Sofia C. Nunes, et al.
Izdano: (2018-06-01)

Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
od: Setterblad, N, et al.
Izdano: (2004)

Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect.
od: Yijun Chen, et al.
Izdano: (2009-09-01)

Bringing H2AX into the angiogenesis family.
od: Rankin, E, et al.
Izdano: (2009)

Oxygen sensing and the DNA-damage response.
od: Hammond, E, et al.
Izdano: (2007)

Hypoxia-Inducible Regulation of a Prodrug-Activating Enzyme for Tumor-Specific Gene Therapy
od: Toru Shibata, et al.
Izdano: (2002-01-01)

Antigen presentation by MHC-dressed cells
od: Masafumi eNakayama
Izdano: (2015-01-01)